Strides Pharma Science Limited

₹1,036As of Sun 8 Nov 2026, 12:00 UTC
NSE:STARHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 10.46%
Div yield 0.48%
ROE 20.31%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.36
PE TTM 15.48
TSR TTM 11.35%
Mkt cap ₹95.48B
ROIC 11.48%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1,265
22.11%
(92.40%)
Hold 7|7|8|7|2
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
11.82
12.60
12.19
13.24
5.91%
16.03%
17.66%
15.72%
Revenue₹B
4.677
4.823
4.846
5.053
10.69%
7.77%
2.19%
5.15%
Peers (US$981.0M)
Cap (US$)
PE
1.079B
48.36x
980.8M
24.30x
898.1M
41.23x
970.0M
15.06x
Capital
TTM
5Y
10Y
Leveragex
2.311
0.306
0.223
EBIT/Intx
1.145
0.420
0.423
Own earn%
550.03
(14.90)
(10.00)
Sh yield%
13.75
19.63
28.36
Owners
Insiders/Inst%
3.67
67.64
Short interest%
5.75
SBC / revenue%
0.56
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
15–21
$1 testx
−0.1
Incr. ROIC%
3